Cohance Life

{
  "main_header": {
    "sid": 1003386,
    "name": "Cohance Life",
    "stock_name": "Cohance Life",
    "full_name": "Cohance Lifesciences Ltd",
    "name_url": "stocks-analysis/cohance-life",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "339.95",
    "chg": -17,
    "chgp": "-4.76%",
    "dir": -1,
    "prev_price": "356.95",
    "mcapval": "13,336.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543064,
    "symbol": "COHANCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE03QK01018",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "9.73 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cohance-life-1003386-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cohance Lifesciences Declines 10.90%: Four Key Factors Behind the Steep Slide",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-declines-1090-four-key-factors-behind-the-steep-slide-3825971",
        "imagepath": "",
        "date": "2026-02-07 11:06:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock hits 52-week low at Rs.355.65</p>\n                    <p><strong>3 Feb:</strong> Strong gap up opening with intraday high of Rs.398.90</p>\n                    <p><strong>5 Feb:</strong> New 52-week low at Rs.355.55 amid continued downtrend</p>\n                    <p><strong>6 Feb:</strong> Further 52-week low at Rs.338.35, closing at Rs.339.40</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.380.90</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.339.40</div><di..."
      },
      {
        "title": "Cohance Lifesciences Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3824434",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CohanceLifescie_priceRelatedfactors_3824434.png",
        "date": "2026-02-06 12:17:30",
        "description": "Cohance Lifesciences Ltd has reached a new 52-week low of Rs.338.35, marking a significant decline in its share price amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and financial performance."
      },
      {
        "title": "Why is Cohance Lifesciences Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-cohance-lifesciences-ltd-fallingrising-3823426",
        "imagepath": "",
        "date": "2026-02-06 01:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movements and Market Performance</strong></p>\n<p>The stock has been under pressure for several weeks, with a one-month return of -30.41% compared to the Sensex’s modest decline of -2.49%. Year-to-date, the stock has fallen by 32.46%, significantly underperforming the benchmark index which is down only 2.24%. Over the past year, the stock’s performance has been particularly weak, plunging 68.32% while the Sensex gained 6.44%. Even over longer horizons such as three and five years, Cohance Lifesciences has lagged behind the broader market, delivering negative returns of 26.35% and 27.90% respectively, against Sensex gains of 36.94% and 64.22%.</p>\n<p>On 05-Feb, the stock hit a new 52-week low of ₹339.80, marking a 7.35% intraday decline. The weighted average price indicates that m..."
      },
      {
        "title": "Cohance Lifesciences Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-falls-to-52-week-low-amidst-continued-downtrend-3822148",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CohanceLifescie_priceRelatedfactors_3822148.png",
        "date": "2026-02-05 10:07:52",
        "description": "Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.355.55 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-3817575",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CohanceLifescie_mojoScore_3817575.png",
        "date": "2026-02-03 10:16:54",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with the most up-to-date view of the company's fundamentals, returns, and market performance."
      },
      {
        "title": "Cohance Lifesciences Ltd Opens Strong with Significant Gap Up on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-opens-strong-with-significant-gap-up-on-3-feb-2026-3818181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CohanceLifescie_gapup_3818181.png",
        "date": "2026-02-03 10:07:18",
        "description": "Cohance Lifesciences Ltd commenced trading on 3 Feb 2026 with a notable gap up, opening 5.01% higher than its previous close, signalling a robust start amid positive market conditions in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Cohance Lifesciences Ltd Stock Hits 52-Week Low at Rs.355.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-stock-hits-52-week-low-at-rs35565-3816003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CohanceLifescie_priceRelatedfactors_3816003.png",
        "date": "2026-02-02 09:58:56",
        "description": "Cohance Lifesciences Ltd’s shares declined to a fresh 52-week low of Rs.355.65 on 2 Feb 2026, marking a significant downturn amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures on its valuation and financial metrics."
      },
      {
        "title": "Cohance Lifesciences Ltd Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-hits-52-week-low-amidst-continued-downtrend-3814750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CohanceLifescie_priceRelatedfactors_3814750.png",
        "date": "2026-02-01 14:07:24",
        "description": "Cohance Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.367.35 today, marking a significant decline in its stock price amid broader market volatility and sector underperformance."
      },
      {
        "title": "Cohance Lifesciences Ltd Stock Falls to 52-Week Low of Rs.368.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-stock-falls-to-52-week-low-of-rs3685-3807653",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CohanceLifescie_priceRelatedfactors_3807653.png",
        "date": "2026-01-28 11:11:55",
        "description": "Cohance Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.368.5 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics."
      }
    ],
    "total": 503,
    "sid": "1003386",
    "stock_news_url": "https://www.marketsmojo.com/news/cohance-lifesciences-1003386"
  },
  "announcements": [
    {
      "caption": "Cohance Lifesciences Limited Has Informed The Exchange About USFDA Announcement.",
      "datetime": "04-Feb-2026",
      "details": "USFDA announcement",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "02-Feb-2026",
      "details": "Resignation of Company Secretary and Compliance Officer of the Company w.e.f close of business hours on February 4 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "22-Jan-2026",
      "details": "Results Conference Call",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 25 Sep 20",
          "dt": "2020-09-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Cohance Lifesciences Declines 10.90%: Four Key Factors Behind the Steep Slide

2026-02-07 11:06:11

Key Events This Week

2 Feb: Stock hits 52-week low at Rs.355.65

3 Feb: Strong gap up opening with intraday high of Rs.398.90

5 Feb: New 52-week low at Rs.355.55 amid continued downtrend

6 Feb: Further 52-week low at Rs.338.35, closing at Rs.339.40

Week Open

Rs.380.90

Week Close

Rs.339.40

Read full news article

Cohance Lifesciences Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-02-06 12:17:30

Cohance Lifesciences Ltd has reached a new 52-week low of Rs.338.35, marking a significant decline in its share price amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and financial performance.

Read full news article

Why is Cohance Lifesciences Ltd falling/rising?

2026-02-06 01:00:06

Recent Price Movements and Market Performance

The stock has been under pressure for several weeks, with a one-month return of -30.41% compared to the Sensex’s modest decline of -2.49%. Year-to-date, the stock has fallen by 32.46%, significantly underperforming the benchmark index which is down only 2.24%. Over the past year, the stock’s performance has been particularly weak, plunging 68.32% while the Sensex gained 6.44%. Even over longer horizons such as three and five years, Cohance Lifesciences has lagged behind the broader market, delivering negative returns of 26.35% and 27.90% respectively, against Sensex gains of 36.94% and 64.22%.

On 05-Feb, the stock hit a new 52-week low of ₹339.80, marking a 7.35% intraday decline. The weighted average price indicates that m...

Read full news article

Cohance Lifesciences Ltd Falls to 52-Week Low Amidst Continued Downtrend

2026-02-05 10:07:52

Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.355.55 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics.

Read full news article

Cohance Lifesciences Ltd is Rated Sell

2026-02-03 10:16:54

Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with the most up-to-date view of the company's fundamentals, returns, and market performance.

Read full news article

Cohance Lifesciences Ltd Opens Strong with Significant Gap Up on 3 Feb 2026

2026-02-03 10:07:18

Cohance Lifesciences Ltd commenced trading on 3 Feb 2026 with a notable gap up, opening 5.01% higher than its previous close, signalling a robust start amid positive market conditions in the Pharmaceuticals & Biotechnology sector.

Read full news article

Cohance Lifesciences Ltd Stock Hits 52-Week Low at Rs.355.65

2026-02-02 09:58:56

Cohance Lifesciences Ltd’s shares declined to a fresh 52-week low of Rs.355.65 on 2 Feb 2026, marking a significant downturn amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures on its valuation and financial metrics.

Read full news article

Cohance Lifesciences Ltd Hits 52-Week Low Amidst Continued Downtrend

2026-02-01 14:07:24

Cohance Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.367.35 today, marking a significant decline in its stock price amid broader market volatility and sector underperformance.

Read full news article

Cohance Lifesciences Ltd Stock Falls to 52-Week Low of Rs.368.5

2026-01-28 11:11:55

Cohance Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.368.5 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.

Read full news article

View All News